Fund shareholders of TEMPEST THERAPEUTICS INC
ISIN US87978U2078 · United States · LEI 529900QLMOA3D8VSCN33
- Fund shareholders
- 7
- Of which ETFs
- 2 5 other funds
- Value held
- 474.3K $
- Share of capital
- 1.9 % of 14.3M shares on Mar 25, 2026
This issuer has other securities : Tempest Therapeutics Inc (US87978U1161)
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 128,944 | 211.5K $ | 0.00 % | 0.90 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 104,944 | 172.1K $ | 0.73 % | as of Mar 31, 2026 ↗ | |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 24,318 | 55.4K $ | 0.00 % | 0.17 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 7,495 | 17.1K $ | 0.05 % | as of Feb 28, 2026 ↗ | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 4,421 | 10.1K $ | 0.03 % | as of Feb 28, 2026 ↗ | |
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 3,985 | 7.9K $ | 0.00 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 107 | 212.9 $ | 0.00 % | as of Apr 30, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Dimensional US Core Equity 1 ETF Dimensional ETF Trust | 0.00 % | as of Apr 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 7 | 0 | 274,214 | +53.9 % |
| 2026Q1 | 7 | +2 | 178,143 | +5.5 % |
| 2025Q4 | 5 | 0 | 168,914 | +3.4 % |
| 2025Q3 | 5 | 163,433 |
Institutional managers
17 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 86,990 | 142.7K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 39,068 | 64.1K $ | as of Mar 31, 2026 |
| FMR LLC | 33,225 | 54.5K $ | as of Mar 31, 2026 |
| SABBY MANAGEMENT, LLC | 17,856 | 29.3K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 14,053 | 23K $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 11,444 | 18.8K $ | as of Mar 31, 2026 |
| UBS Group AG | 4,533 | 7.4K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 2,790 | 4.6K $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 2,058 | 3.4K $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 1,529 | 2.5K $ | as of Mar 31, 2026 |
| Federation des caisses Desjardins du Quebec | 292 | 479 $ | as of Mar 31, 2026 |
| JONES FINANCIAL COMPANIES LLLP | 239 | 413 $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 56 | 92 $ | as of Mar 31, 2026 |
| Parallel Advisors, LLC | 18 | 30 $ | as of Mar 31, 2026 |
| CITIGROUP INC | 8 | 13 $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 5 | 8 $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 3 | 5 $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Fund shareholders of TEMPEST THERAPEUTICS INC". https://titelia.com/en/stocks/tempest-therapeutics-inc-US87978U2078